InsiderClue
Stocks · Health care · Pharmaceutical Preparations

GALECTIN THERAPEUTICS INC

GALT Clue Score21
United States Fiscal year ends December CIK 0001133416 Results filed 14 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

83
Insider
Date
Role
Action
Shares
Price
Amount
Khurram Jamil
14 Jul 2026
Chief Medical Officer
Sold after exercise
16,250
$5.13
$83.28K
Khurram Jamil
29 Jun 2026
Chief Medical Officer
Sold after exercise
47,467
$5.04
$239.23K
Harold H. Shlevin
29 Jun 2026
Director
Sold after exercise
22,268
$5.04
$112.23K
Khurram Jamil
26 Jun 2026
Chief Medical Officer
Sold after exercise
2,533
$5.00
$12.67K
Khurram Jamil
26 Jun 2026
Chief Medical Officer
Sold after exercise
2,037
$5.00
$10.19K
Harold H. Shlevin
26 Jun 2026
Director
Sold after exercise
7,732
$5.00
$38.66K
Khurram Jamil
23 Jun 2026
Chief Medical Officer
Sold after exercise
7,557
$3.14
$23.73K
Khurram Jamil
26 May 2026
Chief Medical Officer
Sold after exercise
568
$3.10
$1.76K
Khurram Jamil
2 Jan 2026
Chief Medical Officer
Sold after exercise
13,055
$4.20
$54.79K
Jack W Callicutt
2 Jan 2026
Chief Financial Officer
Sold after exercise
13,914
$4.20
$58.39K
Joel Lewis
2 Jan 2026
President and CEO
Sold after exercise
18,571
$4.20
$77.94K
Khurram Jamil
31 Dec 2025
Chief Medical Officer
Sold after exercise
8,125
$4.07
$33.09K
Harold H. Shlevin
17 Dec 2025
Director
Sold after exercise
4,706
$7.04
$33.12K
Harold H. Shlevin
17 Dec 2025
Director
Sold after exercise
19,793
$7.04
$139.30K
Khurram Jamil
17 Dec 2025
Chief Medical Officer
Sold after exercise
8,500
$7.04
$59.84K
Khurram Jamil
17 Dec 2025
Chief Medical Officer
Sold after exercise
6,463
$7.04
$45.50K
Khurram Jamil
17 Dec 2025
Chief Medical Officer
Sold after exercise
4,479
$7.04
$31.53K
Joel Lewis
17 Dec 2025
President and CEO
Sold after exercise
7,829
$7.06
$55.24K
Harold H. Shlevin
15 Dec 2025
Director
Sold after exercise
8,417
$6.30
$53.03K
Harold H. Shlevin
12 Dec 2025
Director
Sold after exercise
19,793
$6.27
$124.18K
Harold H. Shlevin
9 Dec 2025
Director
Sold after exercise
16,790
$6.27
$105.21K
Harold H. Shlevin
8 Dec 2025
Director
Sold after exercise
20,000
$6.00
$120.04K
Harold H. Shlevin
8 Dec 2025
Director
Sold after exercise
35,000
$6.02
$210.67K
Harold H. Shlevin
8 Dec 2025
Director
Sold after exercise
25,000
$5.95
$148.65K
Harold H. Shlevin
8 Dec 2025
Director
Sold after exercise
20,000
$5.96
$119.24K
Harold H. Shlevin
8 Dec 2025
Director
Sold after exercise
20,000
$5.96
$119.24K
Harold H. Shlevin
8 Dec 2025
Director
Sold after exercise
35,000
$5.95
$208.25K
Harold H. Shlevin
8 Dec 2025
Director
Sold after exercise
4,000
$6.01
$24.02K
Jack W Callicutt
18 Nov 2025
Chief Financial Officer
Sold after exercise
18,210
$6.22
$113.32K
Jack W Callicutt
18 Nov 2025
Chief Financial Officer
Sold after exercise
28,100
$6.22
$174.87K
Joel Lewis
18 Nov 2025
President and CEO
Sold after exercise
6,783
$6.15
$41.72K
Jack W Callicutt
17 Nov 2025
Chief Financial Officer
Sold after exercise
2,323
$6.03
$14.01K
Jack W Callicutt
17 Nov 2025
Chief Financial Officer
Sold after exercise
19,701
$6.03
$118.83K
Jack W Callicutt
17 Nov 2025
Chief Financial Officer
Sold after exercise
9,586
$6.03
$57.82K
Joel Lewis
17 Nov 2025
President and CEO
Sold after exercise
15,680
$6.04
$94.64K
Khurram Jamil
13 Nov 2025
Chief Medical Officer
Sold after exercise
16,250
$5.47
$88.89K
Khurram Jamil
13 Nov 2025
Chief Medical Officer
Sold after exercise
41,500
$5.47
$227.01K
Khurram Jamil
13 Nov 2025
Chief Medical Officer
Sold after exercise
41,500
$5.47
$227.01K
Khurram Jamil
13 Nov 2025
Chief Medical Officer
Sold after exercise
21,867
$5.47
$119.61K
Jack W Callicutt
10 Nov 2025
Chief Financial Officer
Sold after exercise
1,736
$6.03
$10.47K
Jack W Callicutt
10 Nov 2025
Chief Financial Officer
Sold after exercise
1,675
$6.03
$10.09K
Jack W Callicutt
10 Nov 2025
Chief Financial Officer
Sold after exercise
1,880
$6.02
$11.32K
Joel Lewis
10 Nov 2025
President and CEO
Sold after exercise
1,867
$6.03
$11.25K
Jack W Callicutt
5 Nov 2025
Chief Financial Officer
Sold after exercise
200
$6.00
$1.20K
Jack W Callicutt
5 Nov 2025
Chief Financial Officer
Sold after exercise
200
$6.00
$1.20K
Jack W Callicutt
5 Nov 2025
Chief Financial Officer
Sold after exercise
200
$6.00
$1.20K
Joel Lewis
5 Nov 2025
President and CEO
Sold after exercise
200
$6.00
$1.20K
Jack W Callicutt
4 Nov 2025
Chief Financial Officer
Sold after exercise
10,741
$6.07
$65.20K
Jack W Callicutt
4 Nov 2025
Chief Financial Officer
Sold after exercise
8,974
$6.07
$54.47K
Jack W Callicutt
4 Nov 2025
Chief Financial Officer
Sold after exercise
8,914
$6.07
$54.11K
Joel Lewis
4 Nov 2025
President and CEO
Sold after exercise
14,420
$6.07
$87.53K
Jack W Callicutt
3 Nov 2025
Chief Financial Officer
Sold after exercise
1,250
$6.01
$7.51K
Jack W Callicutt
3 Nov 2025
Chief Financial Officer
Sold after exercise
1,260
$6.01
$7.57K
Jack W Callicutt
3 Nov 2025
Chief Financial Officer
Sold after exercise
1,300
$6.01
$7.81K
Joel Lewis
3 Nov 2025
President and CEO
Sold after exercise
1,300
$6.01
$7.81K
Joel Lewis
12 Sep 2025
President and CEO
Sold after exercise
14,000
$6.36
$89.05K
Jack W Callicutt
12 Sep 2025
Chief Financial Officer
Sold after exercise
8,706
$6.44
$56.05K
Jack W Callicutt
23 Dec 2024
Chief Financial Officer
Sold after exercise
40,000
$0.89
$35.49K
Joel Lewis
23 Dec 2024
President and CEO
Sold after exercise
56,000
$0.89
$49.61K
Khurram Jamil
23 Dec 2024
Chief Medical Officer
Sold after exercise
13,654
$0.88
$12.04K
Marc Rubin
22 Feb 2019
Director
Sold after exercise
859
$6.02
$5.17K
Marc Rubin
21 Feb 2019
Director
Sold after exercise
43,326
$6.02
$261.03K
Marc Rubin
21 Feb 2019
Director
Sold after exercise
7,000
$6.00
$42.00K
Marc Rubin
4 Sep 2018
Director
Sold after exercise
11,900
$6.58
$78.26K
Marc Rubin
30 Aug 2018
Director
Sold after exercise
58,100
$6.08
$353.31K
Jack W Callicutt
20 Jun 2018
Chief Financial Officer
Sold after exercise
97,267
$8.08
$786.03K
Jack W Callicutt
19 Jun 2018
Chief Financial Officer
Sold after exercise
128,733
$9.01
$1.16M
Harold H. Shlevin
13 Jun 2018
Chief Operating Officer
Sold after exercise
30,918
$7.79
$240.92K
Peter G Traber
13 Jun 2018
President & CEO
Sold after exercise
100,000
$7.51
$751.00K
Jack W Callicutt
12 Jun 2018
Chief Financial Officer
Sold after exercise
9,294
$7.01
$65.17K
Jack W Callicutt
11 Jun 2018
Chief Financial Officer
Sold after exercise
20,000
$6.38
$127.50K
Jack W Callicutt
8 Jun 2018
Chief Financial Officer
Sold after exercise
100,000
$5.75
$575.00K
Harold H. Shlevin
8 Jun 2018
Chief Operating Officer
Sold after exercise
104,294
$5.77
$602.05K
Peter G Traber
8 Jun 2018
President & CEO
Sold after exercise
70,000
$5.86
$410.00K
Harold H. Shlevin
7 Jun 2018
Chief Operating Officer
Sold after exercise
100,891
$5.21
$525.27K
Harold H. Shlevin
6 Jun 2018
Chief Operating Officer
Sold after exercise
9,078
$5.15
$46.75K
Harold H. Shlevin
5 Jun 2018
Chief Operating Officer
Sold after exercise
9,924
$5.16
$51.18K
Harold H. Shlevin
4 Jun 2018
Chief Operating Officer
Sold after exercise
10,907
$5.15
$56.17K
Harold H. Shlevin
1 Jun 2018
Chief Operating Officer
Sold after exercise
69,200
$5.10
$352.92K
Harold H. Shlevin
31 May 2018
Chief Operating Officer
Sold after exercise
50,000
$5.00
$250.00K
Jack W Callicutt
31 May 2018
Chief Financial Officer
Sold after exercise
46,651
$5.00
$233.26K
Theodore Daniel Zucconi
16 Apr 2018
Director
Sold after exercise
4,000
$3.58
$14.32K
Jack W Callicutt
4 Apr 2018
Chief Financial Officer
Sold after exercise
3,349
$5.00
$16.75K
Showing 250 of 254 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 386
Amendments (4/A) skipped 24
Filings about a different issuer 0
Unreadable filings 0
Joint filings 35
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 83
Sales at will 66
Transactions with no price 0
Shares from compensation/vesting 46,004,203
Sales filed before the plan box existed 58
History held since 9 Feb 2007